Dexamethasone in Controlling Dyspnea in Patients With Cancer
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well dexamethasone works in controlling dyspnea in patients
with cancer. Dexamethasone may help control dyspnea (shortness of breath) and improve lung
function and quality of life in cancer patients.